Display Settings:

Format

Send to:

Choose Destination

    Bioorg Med Chem Lett. 2003 Apr 17;13(8):1495-8.

    Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors.

    Tomczuk B, Lu T, Soll RM, Fedde C, Wang A, Murphy L, Crysler C, Dasgupta M, Eisennagel S, Spurlino J, Bone R.

    3-Dimensional Pharmaceuticals, Inc., 665 Stockton Drive, Exton, PA 19341, USA. bruce.tomczuk@3dp.com

    Although thrombin has been extensively researched with many examples of potent and selective inhibitors, the key characteristics of oral bioavailability and long half-life have been elusive. We report here a novel series non-peptidic phenyl-based, highly potent, highly selective and orally bioavailable thrombin inhibitors using oxyguanidines as guanidine-mimetics.

    PMID: 12668020 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read